- Home
- UDMY vs BBOT Comparison
UDMY vs BBOT Comparison
Compare UDMY & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDMY
- BBOT
- Stock Information
- Founded
- UDMY 2009
- BBOT 2016
- Country
- UDMY United States
- BBOT United States
- Employees
- UDMY N/A
- BBOT N/A
- Industry
- UDMY Other Consumer Services
- BBOT Biotechnology: Pharmaceutical Preparations
- Sector
- UDMY Real Estate
- BBOT Health Care
- Exchange
- UDMY Nasdaq
- BBOT Nasdaq
- Market Cap
- UDMY 1.0B
- BBOT 1.1B
- IPO Year
- UDMY 2021
- BBOT N/A
- Fundamental
- Price
- UDMY $5.12
- BBOT $12.40
- Analyst Decision
- UDMY Buy
- BBOT Strong Buy
- Analyst Count
- UDMY 10
- BBOT 4
- Target Price
- UDMY $9.67
- BBOT $24.75
- AVG Volume (30 Days)
- UDMY 2.2M
- BBOT 133.6K
- Earning Date
- UDMY 10-29-2025
- BBOT 11-12-2025
- Dividend Yield
- UDMY N/A
- BBOT N/A
- EPS Growth
- UDMY N/A
- BBOT N/A
- EPS
- UDMY N/A
- BBOT N/A
- Revenue
- UDMY $795,801,000.00
- BBOT N/A
- Revenue This Year
- UDMY $2.52
- BBOT N/A
- Revenue Next Year
- UDMY $2.48
- BBOT N/A
- P/E Ratio
- UDMY N/A
- BBOT N/A
- Revenue Growth
- UDMY 2.53
- BBOT N/A
- 52 Week Low
- UDMY $4.86
- BBOT $8.50
- 52 Week High
- UDMY $10.61
- BBOT $14.04
- Technical
- Relative Strength Index (RSI)
- UDMY 33.66
- BBOT N/A
- Support Level
- UDMY $4.86
- BBOT N/A
- Resistance Level
- UDMY $5.39
- BBOT N/A
- Average True Range (ATR)
- UDMY 0.18
- BBOT 0.00
- MACD
- UDMY 0.00
- BBOT 0.00
- Stochastic Oscillator
- UDMY 35.07
- BBOT 0.00
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.
About BBOT BridgeBio Oncology Therapeutics Inc. Common Stock
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.